Daiichi Sankyo Co Ltd logo

Daiichi Sankyo Co Ltd

$ 27.45 -0.67 (-2.38%) 10:08 PM EST
On watch
P/E:
153.45
P/B:
5.54
Market Cap:
$ 54.46B
Enterprise V:
$ 49.94B
Volume:
1.26K
Avg Vol (2M):
3.56K
Also Trade In:
Volume:
1.26K
Market Cap $:
54.46B
PE Ratio:
153.45
Avg Vol (2-Month):
3.56K
Enterprise Value $:
49.94B
PB Ratio:
5.54
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Daiichi Sankyo Co Ltd is a Japanese pharmaceutical company. It focuses on research and development for bringing up forth novel therapies in oncology, including immune oncology, with further focus on new areas, such as pain management, neurodegenerative diseases, heart and kidney diseases. Daiichi, through the pharmaceutical technology platform, develops processes for manufacturing of quality pharmaceuticals that meet desired efficacy and safety parameters. Daiichi is involved in process technology, biotechnology, formulation technology, analytical and quality evaluation technology. Its products brand includes PRALIA, MOVANTIK, LIXIANA, levofloxacin, Injectafer, and others. The company has its business operations in Europe, North America, and Japan. Most of its revenue comes from Japan.

Financials

DSKYF's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:DSKYF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 8,947.509
EPS (TTM) ($) 0.228
Beta 0.23
Volatility % 33.78
14-Day RSI 43.57
14-Day ATR ($) 1.244681
20-Day SMA ($) 29.31475
12-1 Month Momentum % 4.79
52-Week Range ($) 19.45 - 33.64
Shares Outstanding (Mil) 1,916.79

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Daiichi Sankyo Co Ltd Filings

Document Form Filing Date
No Filing Data

Daiichi Sankyo Co Ltd Analysis

Share your research

Headlines

See More
No news.